Evidence map›Paper›PMID 42368148›Full record

ArticleACS omega2026

Engineering Three-Chamber Core-Sheath Cellulose Acetate Nanofibers via Multifluid Electrospinning for Enhanced Wettability and Tunable Initial Drug Release Behavior.

Yubo Liu, Xiaohong Chen, Jiale Pan, Boyu Si, Xubao He, Guangjian Lu, Ping Liu, Xiangde Lin, Hui Yang

Abstract read
In one paragraph

Article in ACS omega, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Yubo LiuJinshan District Central Hospital Affiliated to Shanghai University of Medicine & Health Sciences, Shanghai 201599, China.ORCID https://orcid.org/0009-0004-4616-7196
Xiaohong ChenSchool of Materials and Chemistry, University of Shanghai for Science & Technology, Shanghai 200093, China.ORCID https://orcid.org/0009-0000-0310-1315
Jiale PanShanghai Institute of Medical Device Testing, Shanghai 201318, China.
Boyu SiSchool of Medical Instrument, Shanghai University of Medicine & Health Sciences, Shanghai 201318, China.
Xubao HeSchool of Medical Instrument, Shanghai University of Medicine & Health Sciences, Shanghai 201318, China.
Guangjian LuShanghai Institute of Medical Device Testing, Shanghai 201318, China.
Ping LiuSchool of Materials and Chemistry, University of Shanghai for Science & Technology, Shanghai 200093, China.ORCID https://orcid.org/0000-0002-9218-3531
Xiangde LinSchool of Medical Instrument, Shanghai University of Medicine & Health Sciences, Shanghai 201318, China.ORCID https://orcid.org/0000-0003-4381-8155
Hui YangInnovation Center for Intelligent Ophthalmic Technologies and Equipment, Shanghai University of Medicine and Health Sciences, Shanghai 201318, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Traditional materials are often constrained by their structural and functional limitations. To address this challenge, multifluid electrospinning has emerged as an advanced nanofabrication technique capable of producing complex structures with enhanced performance. Inspired by rocket stage separation, we utilized cellulose acetate, a biomacromolecule derivative, as the polymer matrix to fabricate complex three-chamber core-sheath nanofibers with TEM-verified structures and enhanced performance. The surface wettability of the fibers was effectively tuned by adjusting the polyvinylpyrrolidone (PVP) concentration in the outermost layer, where a higher PVP content enabled a rapid transition from hydrophobic to hydrophilic states. Furthermore, the strategic colocalization of PVP and drug in the sheath layer yielded a biphasic release profile, characterized by an initial burst followed by a sustained release phase, which successfully eliminated the tailing effect in the late stage. Increasing the drug loading in the outer layer from 1% to 3% significantly enhanced the initial release amount from 65.15% ± 11.19% to 79.26% ± 0.42%. This work establishes a robust material design strategy based on structural and componential control, offering new insights into the development of high-performance nanofibrous systems for tailored drug delivery and functional applications.

Identifiers

PMID42368148
PMCPMC13295022

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.